References
- Alnaji, L., and Ridha, M. (2013) The role of supply chain applications in Jordanian Pharmacies: A case study on pharmacies in the capital city Amman. Industrial Engineering Letters, 3(1), 65–71.
- Arthritis Foundation. (n.d.) Afraid of drug side effects? http://www.arthritis.org/living-with-arthritis/treatments/medication/side-effects/understanding-medication-risks.php
- Åsberg, M., Cronholm, B., Sjöqvist, F., and Tuck, D. (1970) Correlation of subjective side effects with plasma concentrations of nortriptyline. BMJ, 4(5726), 18–21.
- Brown, M. T., and Bussell, J. K. (2011) Medication adherence: WHO cares? Pp. 304–314 in Mayo Clinic Proceedings (Vol. 86, No. 4. Elsevier.
- Candan, G., and Yazgan, H. R. (2016) A novel approach for inventory problem in the pharmaceutical supply chain. DARU Journal of Pharmaceutical Sciences, 24(1), 1.
- Costa, A. (2015) Hybrid genetic optimization for solving the batch-scheduling problem in a pharmaceutical industry. Computers & Industrial Engineering, 79, 130–147.
- Crestor Lawsuit Center. (2011) Crestor lawsuit/Crestor side effects. http://crestorlawsuit-info.com/
- Duke, J., Friedlin, J., and Ryan, P. (2011) A quantitative analysis of adverse events and “overwarning” in drug labeling. Archives of Internal Medicine, 171(10), 941–954.
- Edwards, I. R., and Aronson, J. K. (2000) Adverse drug reactions: Definitions, diagnosis, and management. The Lancet, 356(9237), 1255–1259.
- Hanson, S. E., and He, Y. (2016). Modeling an Efficient Planning Methodology in Pharmaceutical Supply Chain (Doctoral dissertation). Cambridge, Massachusetts: Massachusetts Institute of Technology.
- Kopanos, G. M., Méndez, C. A., and Puigjaner, L. (2010) MIP-based decomposition strategies for large-scale scheduling problems in multiproduct multistage batch plants: A benchmark scheduling problem of the pharmaceutical industry. European Journal of Operational Research, 207(2), 644–655.
- Laínez, J. M., Schaefer, E., and Reklaitis, G. V. (2012) Challenges and opportunities in enterprise-wide optimization in the pharmaceutical industry. Computers & Chemical Engineering, 47, 19–28.
- Mayo Foundation for Medical Education and Research. (2014) High blood pressure (hypertension). http://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/diuretics/art-20048129?pg=2
- Mercola. (2011) Average drug label lists over whopping 70 side effects. http://articles.mercola.com/sites/articles/archive/2011/06/09/average-drug-label-lists-over-whopping-70-side-effects.aspx
- Mousazadeh, M., Torabi, S. A., and Zahiri, B. (2015) A robust possibilistic programming approach for pharmaceutical supply chain network design. Computers & Chemical Engineering, 82, 115–128.
- Nakamichi, T., and Loftus, P. (2015) Takeda pharmaceutical to pay up to $2.4 billion to settle U.S. lawsuits. http://www.wsj.com/articles/takeda-pharmaceutical-to-pay-up-to-2-4-billion-to-settle-u-s-lawsuits-1430270490
- Narayana, S. A., Pati, R. K., and Vrat, P. (2012) Research on management issues in the pharmaceutical industry: A literature review. International Journal of Pharmaceutical and Healthcare Marketing, 6(4), 351–375.
- Papageorgiou, L. G. (2009) Supply chain optimisation for the process industries: Advances and opportunities. Computers & Chemical Engineering, 33(12), 1931–1938.
- Ravindran, A. R., and Warsing Jr., D. P. (2012) Supply Chain Engineering: Models and Applications. CRC Press: Boca Raton, FL.
- Reddy, S. (2014) Side effects: Telling the real From the imagined. http://www.wsj.com/articles/side-effects-telling-the-real-from-the-imagined-1404772436
- Shilhavy, B. (2014) Thousands sue for damages against cholesterol drugs as Big Pharma defends billion dollar industry. http://healthimpactnews.com/2014/thousands-sue-for-damages-against-cholesterol-drugs-as-big-pharma-defends-billion-dollar-industry/
- Stefansson, H., Sigmarsdottir, S., Jensson, P., and Shah, N. (2011) Discrete and continuous time representations and mathematical models for large production scheduling problems: A case study from the pharmaceutical industry. European Journal of Operational Research, 215(2), 383–392.
- U.S. Department of Health and Human Services. (2017) Drugs@FDA glossary of terms. http://www.fda.gov/Drugs/InformationOnDrugs/ucm079436.htm
- U.S. Food and Drug Administration. (2015a) Think it through: Managing the benefits and risks of medicines. https://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm143558.htm
- U.S. Food and Drug Administration. (2015b) Medicines and you: A guide for older adults. https://www.fda.gov/Drugs/ResourcesForYou/ucm163959.htm
- Venditti, L., Pacciarelli, D., and Meloni, C. (2010) A tabu search algorithm for scheduling pharmaceutical packaging operations. European Journal of Operational Research, 202(2), 538–546.
- Young, S. D., and Oppenheimer, D. M. (2006) Different methods of presenting risk information and their influence on medication compliance intentions: Results of three studies. Clinical Therapeutics, 28(1), 129–139.
- Yu, X., Li, C., Shi, Y., and Yu, M. (2010) Pharmaceutical supply chain in China: Current issues and implications for health system reform. Health Policy, 97(1), 8–15.